ABVC BioPharma, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-4.2M | $-11.0M | $-32.3K | $-23.2K | $-226.4K | $-1.1M | $-1.2M | $-1.9M |
| Depreciation & Amortization | — | — | — | — | $23.9K | $33.0K | $34.2K | $45.2K |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $155.4K | $398.0K | — | — | — | — | — | — |
| Net Cash from Operating Activities | $-1.5M | $-3.5M | $3.4K | $1.2K | $-37.8K | $-915.1K | $-1.6M | $-1.0M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | $0 | $350 | $29.8K | $-1.4K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | $0 | $0 | $0 | $-19.5K | $-38.7K | $-11.4K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $1.6M | $2.7M | $0 | $0 | $25.0K | $876.3K | $1.7M | $1.1M |
| Net Change in Cash | $74.7K | $-821.3K | $3.4K | $1.2K | $-12.8K | $-58.4K | $69.0K | $2.8K |
| Free Cash Flow | — | — | — | — | $-37.8K | $-915.5K | $-1.6M | $-1.0M |